Meet COMPASS
Custom Organoid Modelling Platform for Accurate and Speedy Solutions
Built for any ANY Drug Modality against ANY Solid Cancer Indication.
Spanios' proprietary method creates patient-derived 3D tumor models tha are stable, biobanked, and disrupt how novel therapies are efficacy tested in the pre-clinical stage.
We overcome limitations of traditional approaches such as xenografts and animal models by creating a resilient replica of host tumor environments. This keeps the focus on identifying new pathways, bringing optimal treatments to patients faster than ever before.
With Spanios’ technology, scientists and researchers benefit from a host of advantages over traditional approaches.
With Spanios’ technology, scientists and researchers benefit from a host of advantages over traditional approaches.
Tumoroids are the perfectly optimized human tool for performing:
- biomarker discovery
- drug selection & ratios for more informed treatment decisions
- assessment of combination therapies
- drug rescue & repurposing
- search for predictive signatures of drug failure, toxicity, response and escape mechanisms
- derisking clinical trials and patient stratification
- testing within the platform to facilitate precision cancer immunotherapy
- contraindication discovery
-assessing drug performance across a variety of oxygenation and pH environments
- drug selection & ratios for more informed treatment decisions
- assessment of combination therapies
- drug rescue & repurposing
- search for predictive signatures of drug failure, toxicity, response and escape mechanisms
- derisking clinical trials and patient stratification
- testing within the platform to facilitate precision cancer immunotherapy
- contraindication discovery
-assessing drug performance across a variety of oxygenation and pH environments
HOW IT WORKS
Advanced Screening Platform
Data is the foundation of research and the driver of innovation.
That’s why Spanios is investing in a sophisticated software platform that synthesizes structured data derived from our proprietary models and transforms it into actionable intelligence. Our approach provides researchers and clinicians with the confidence in knowing treatment recommendations and care decisions are backed by real lab data.
Data is the foundation of research and the driver of innovation.
That’s why Spanios is investing in a sophisticated software platform that synthesizes structured data derived from our proprietary models and transforms it into actionable intelligence. Our approach provides researchers and clinicians with the confidence in knowing treatment recommendations and care decisions are backed by real lab data.
THERAPEUTIC AREAS
Neuroendocrine
Sarcomas
Gallbladder
Gastric & Esophageal
Bladder
Breast
Glioblastoma
Ovarian
Pancreatic
Prostate, Lung & Colorectal
